CME ACTIVITY
Optimizing Therapeutic Decision Making: PSA as a Biomarker for Benign Prostatic Hyperplasia Disease Progression
Proceedings from a Roundtable Symposium
Activity Date: April 2003
Activity Info: Volume 3, (4D)
 
 
 


Supported by an educational grant from
GlaxoSmithKline
 
 
     
 
Home | Contact Us | View Account | Need Help?